H.R.891 - Medication Therapy Management Benefits Act of 2011

To amend part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. view all titles (2)

All Bill Titles

  • Official: To amend part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. as introduced.
  • Short: Medication Therapy Management Benefits Act of 2011 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 4
  • All-Time: 3,214
 
Introduced
 
House
Passes
 
Senate
Passes
 
President
Signs
 

 
03/03/11
 
 
 
 
 
 
 

Sponsor

Representative

Cathy McMorris Rodgers

R-WA

View Co-Sponsors (62)

Official Summary

Medication Therapy Management Benefits Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require that the annual comprehensive medication review include creation of a personal medication record and a recom

Official Summary

Medication Therapy Management Benefits Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require that the annual comprehensive medication review include creation of a personal medication record and a recommended medication action plan in consultation with the individual and the prescriber. Requires medication therapy management (MTM) services to include targeted medication reviews furnished person-to-person by a licensed pharmacist offered at least once every quarter to:
(1) assess medication use since the last annual comprehensive medication review,
(2) monitor unresolved issues, or
(3) identify problems with new drug therapies or if the individual has experienced a transition in care. Increases the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management (MTM) services. Requires a prescription drug plan (PDP) sponsor to identify a process, subject to approval by the Secretary of Health and Human Services (HHS), that allows licensed pharmacists or other qualified providers to identify potential enrollees for MTM interventions where such individuals are not targeted beneficiaries or are not otherwise offered MTM services. Requires any MTM program to offer both comprehensive and targeted medication reviews to individuals dually eligible for both Medicare and Medicaid (under SSA title XIX), regardless of whether they are MTM-targeted beneficiaries. Requires a PDP sponsor to offer any willing pharmacy in its network the ability to provide MTM services. Requires the PDP sponsor to reimburse pharmacists and other entities furnishing MTM services based on the resources used and the time required to provide such services. Directs the Secretary to:
(1) establish measures and standards for data collection by PDP sponsors to evaluate performance of pharmacies and other entities in furnishing MTM services; and
(2) support the continued development and refinement of performance measures. Provides pharmacies and other entities that furnish MTM services with additional incentive payments based on their performance in meeting quality measures established under this Act.

...Read the Rest


Latest Letters to Congress

See All Letters (1)
 


Vote on This Bill

100% Users Support Bill

2 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC